A randomized controlled trial of a proportionate universal parenting program delivery model (E-SEE Steps) to enhance child social-emotional wellbeing.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 09 08 2021
accepted: 21 12 2021
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 15 4 2022
Statut: epublish

Résumé

Evidence for parenting programs to improve wellbeing in children under three is inconclusive. We investigated the fidelity, impact, and cost-effectiveness of two parenting programs delivered within a longitudinal proportionate delivery model ('E-SEE Steps'). Eligible parents with a child ≤ 8 weeks were recruited into a parallel two-arm, assessor blinded, randomized controlled, community-based, trial with embedded economic and process evaluations. Post-baseline randomization applied a 5:1 (intervention-to-control) ratio, stratified by primary (child social-emotional wellbeing (ASQ:SE-2)) and key secondary (maternal depression (PHQ-9)) outcome scores, sex, and site. All intervention parents received the Incredible Years® Baby Book (IY-B), and were offered the targeted Infant (IY-I)/Toddler (IY-T) program if eligible, based on ASQ:SE-2/PHQ-9 scores. Control families received usual services. Fidelity data were analysed descriptively. Primary analysis applied intention to treat. Effectiveness analysis fitted a marginal model to outcome scores. Cost-effectiveness analysis involved Incremental Cost-Effectiveness Ratios (ICERs). The target sample (N = 606) was not achieved; 341 mothers were randomized (285:56), 322 (94%) were retained to study end. Of those eligible for the IY-I (n = 101), and IY-T (n = 101) programs, 51 and 21 respectively, attended. Eight (of 14) groups met the 80% self-reported fidelity criteria. No significant differences between arms were found for adjusted mean difference scores; ASQ:SE-2 (3.02, 95% CI: -0.03, 6.08, p = 0.052), PHQ-9 (-0.61; 95% CI: -1.34, 0.12, p = 0.1). E-SEE Steps had higher costs, but improved mothers' Health-related Quality of Life (0.031 Quality Adjusted Life Year (QALY) gain), ICER of £20,062 per QALY compared to control. Serious adverse events (n = 86) were unrelated to the intervention. E-SEE Steps was not effective, but was borderline cost-effective. The model was delivered with varying fidelity, with lower-than-expected IY-T uptake. Changes to delivery systems and the individual programs may be needed prior to future evaluation. International Standard Randomized Controlled Trial Number: ISRCTN11079129.

Sections du résumé

BACKGROUND
Evidence for parenting programs to improve wellbeing in children under three is inconclusive. We investigated the fidelity, impact, and cost-effectiveness of two parenting programs delivered within a longitudinal proportionate delivery model ('E-SEE Steps').
METHODS
Eligible parents with a child ≤ 8 weeks were recruited into a parallel two-arm, assessor blinded, randomized controlled, community-based, trial with embedded economic and process evaluations. Post-baseline randomization applied a 5:1 (intervention-to-control) ratio, stratified by primary (child social-emotional wellbeing (ASQ:SE-2)) and key secondary (maternal depression (PHQ-9)) outcome scores, sex, and site. All intervention parents received the Incredible Years® Baby Book (IY-B), and were offered the targeted Infant (IY-I)/Toddler (IY-T) program if eligible, based on ASQ:SE-2/PHQ-9 scores. Control families received usual services. Fidelity data were analysed descriptively. Primary analysis applied intention to treat. Effectiveness analysis fitted a marginal model to outcome scores. Cost-effectiveness analysis involved Incremental Cost-Effectiveness Ratios (ICERs).
RESULTS
The target sample (N = 606) was not achieved; 341 mothers were randomized (285:56), 322 (94%) were retained to study end. Of those eligible for the IY-I (n = 101), and IY-T (n = 101) programs, 51 and 21 respectively, attended. Eight (of 14) groups met the 80% self-reported fidelity criteria. No significant differences between arms were found for adjusted mean difference scores; ASQ:SE-2 (3.02, 95% CI: -0.03, 6.08, p = 0.052), PHQ-9 (-0.61; 95% CI: -1.34, 0.12, p = 0.1). E-SEE Steps had higher costs, but improved mothers' Health-related Quality of Life (0.031 Quality Adjusted Life Year (QALY) gain), ICER of £20,062 per QALY compared to control. Serious adverse events (n = 86) were unrelated to the intervention.
CONCLUSIONS
E-SEE Steps was not effective, but was borderline cost-effective. The model was delivered with varying fidelity, with lower-than-expected IY-T uptake. Changes to delivery systems and the individual programs may be needed prior to future evaluation.
TRIAL REGISTRATION
International Standard Randomized Controlled Trial Number: ISRCTN11079129.

Identifiants

pubmed: 35377882
doi: 10.1371/journal.pone.0265200
pii: PONE-D-21-24712
pmc: PMC8979462
doi:

Banques de données

ISRCTN
['ISRCTN11079129']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0265200

Subventions

Organisme : Department of Health
ID : NIHR200166
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR200167
Pays : United Kingdom
Organisme : Department of Health
ID : 13/93/10
Pays : United Kingdom

Déclaration de conflit d'intérêts

All authors were supported by the grant, National Institute for Health Research (NIHR) Public Health Research (PHR) (ref 13/93/10). TB, SB, KP and GR were also supported by the NIHR Yorkshire and Humber Applied Research Collaboration (ARC-YH; Ref: NIHR200166, see https://www.arc-yh.nihr.ac.uk,); VB by the South West Peninsula ARC (PenARC, Ref: NIHR200167, see https://arc-swp.nihr.ac.uk). Public Health England supported research sites’ excess treatment costs (no award number). This above funding does not alter our adherence to PLOS ONE policies on sharing data and materials. In addition, TB is a voluntary Trustee for Children’s Early Intervention Trust (CEIT). Early Intervention Wales Training (EIWT) is owned by CEIT and offers training courses, including Incredible Years® (IY). Trustees do not benefit financially from trainings or CEIT/EIWT activities. ESEE study trainings were arranged via the IY developer in the U.S., not via EIWT.

Références

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008225
pubmed: 22336837
PLoS One. 2019 Apr 16;14(4):e0215461
pubmed: 30990855
Clin Child Fam Psychol Rev. 2019 Sep;22(3):388-405
pubmed: 30806864
Qual Life Res. 2014 Mar;23(2):403-11
pubmed: 23943259
J Consult Clin Psychol. 2005 Oct;73(5):872-879
pubmed: 16287387
Trials. 2019 Feb 28;20(1):151
pubmed: 30819224
BMJ Open. 2018 Dec 19;8(12):e026906
pubmed: 30573493
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6
pubmed: 9255702
J Child Psychol Psychiatry. 2020 Feb;61(2):195-204
pubmed: 31535379
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
BMJ Open. 2018 Feb 8;8(2):e014899
pubmed: 29439064
Lancet. 2016 Jan 9;387(10014):146-55
pubmed: 26474809
J Child Psychol Psychiatry. 2018 Jun;59(6):711-713
pubmed: 29808490
Dev Psychopathol. 2019 Dec;31(5):1851-1862
pubmed: 31370916
J Child Fam Stud. 2016;25(11):3309-3321
pubmed: 27795658
Med Care. 1997 May;35(5):522-37
pubmed: 9140339
Clin Child Fam Psychol Rev. 2019 Sep;22(3):367-387
pubmed: 30796674
Med Care. 1999 Feb;37(2):126-39
pubmed: 10024117

Auteurs

Tracey Bywater (T)

Department of Health Sciences, University of York, York, North Yorkshire, United Kingdom.

Vashti Berry (V)

College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.

Sarah Blower (S)

Department of Health Sciences, University of York, York, North Yorkshire, United Kingdom.

Matthew Bursnall (M)

Sheffield Clinical Trials Research Unit, Sheffield, South Yorkshire, United Kingdom.

Edward Cox (E)

Centre for Health Economics, University of York, York, North Yorkshire, United Kingdom.

Amanda Mason-Jones (A)

Department of Health Sciences, University of York, York, North Yorkshire, United Kingdom.

Sinead McGilloway (S)

Centre for Mental Health and Community Research, Maynooth University, Maynooth, Co Kildare, Ireland.

Kirsty McKendrick (K)

Sheffield Clinical Trials Research Unit, Sheffield, South Yorkshire, United Kingdom.

Siobhan Mitchell (S)

College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.

Kate Pickett (K)

Department of Health Sciences, University of York, York, North Yorkshire, United Kingdom.

Gerry Richardson (G)

Centre for Health Economics, University of York, York, North Yorkshire, United Kingdom.

Kiera Solaiman (K)

Sheffield Clinical Trials Research Unit, Sheffield, South Yorkshire, United Kingdom.

M Dawn Teare (MD)

Institute of Health and Society University, Newcastle upon Tyne, Tyne and Wear, United Kingdom.

Simon Walker (S)

Centre for Health Economics, University of York, York, North Yorkshire, United Kingdom.

Karen Whittaker (K)

School of Nursing, University of Central Lancashire, Preston, Lancashire, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH